Bank of Montreal’s Celldex Therapeutics CLDX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-19,607
| Closed | -$356K | – | 3202 |
|
2025
Q1 | $356K | Buy |
+19,607
| New | +$356K | ﹤0.01% | 2160 |
|
2023
Q2 | – | Sell |
-26,980
| Closed | -$1.12M | – | 3569 |
|
2023
Q1 | $1.12M | Sell |
26,980
-1,968
| -7% | -$82K | ﹤0.01% | 1766 |
|
2022
Q4 | $1.32M | Buy |
+28,948
| New | +$1.32M | ﹤0.01% | 1709 |
|
2021
Q2 | – | Sell |
-60
| Closed | -$1K | – | 3703 |
|
2021
Q1 | $1K | Hold |
60
| – | – | ﹤0.01% | 4565 |
|
2020
Q4 | $1K | Hold |
60
| – | – | ﹤0.01% | 4374 |
|
2020
Q3 | $1K | Hold |
60
| – | – | ﹤0.01% | 4263 |
|
2020
Q2 | $1K | Hold |
60
| – | – | ﹤0.01% | 4178 |
|
2020
Q1 | $0 | Hold |
60
| – | – | ﹤0.01% | 3816 |
|
2019
Q4 | $0 | Buy |
+60
| New | – | ﹤0.01% | 4302 |
|
2018
Q2 | – | Sell |
-333
| Closed | -$12K | – | 4368 |
|
2018
Q1 | $12K | Hold |
333
| – | – | ﹤0.01% | 3416 |
|
2017
Q4 | $14K | Buy |
+333
| New | +$14K | ﹤0.01% | 3359 |
|
2017
Q2 | – | Sell |
-3,256
| Closed | -$176K | – | 3811 |
|
2017
Q1 | $176K | Hold |
3,256
| – | – | ﹤0.01% | 2329 |
|
2016
Q4 | $186K | Buy |
3,256
+3,206
| +6,412% | +$183K | ﹤0.01% | 2272 |
|
2016
Q3 | $3K | Sell |
50
-2,809
| -98% | -$169K | ﹤0.01% | 3523 |
|
2016
Q2 | $188K | Buy |
2,859
+2,791
| +4,104% | +$184K | ﹤0.01% | 2278 |
|
2016
Q1 | $4K | Sell |
68
-6
| -8% | -$353 | ﹤0.01% | 3570 |
|
2015
Q4 | $17K | Buy |
74
+6
| +9% | +$1.38K | ﹤0.01% | 3217 |
|
2015
Q3 | $11K | Sell |
68
-3,335
| -98% | -$539K | ﹤0.01% | 3194 |
|
2015
Q2 | $1.29M | Buy |
3,403
+2,368
| +229% | +$896K | ﹤0.01% | 1432 |
|
2015
Q1 | $433K | Sell |
1,035
-556
| -35% | -$233K | ﹤0.01% | 1839 |
|
2014
Q4 | $436K | Buy |
1,591
+4
| +0.3% | +$1.1K | ﹤0.01% | 1811 |
|
2014
Q3 | $309K | Sell |
1,587
-651
| -29% | -$127K | ﹤0.01% | 1928 |
|
2014
Q2 | $548K | Buy |
+2,238
| New | +$548K | ﹤0.01% | 1690 |
|